QIUZhi-bing , CHENXin , XUMing , WANGLi-ming , JIANGYing-shuo , HUANGFu-hua , XIAOLi-qiong , YANGTing , ZHANGYang-bo
  • Department of Cardiovascular Surgery, Nanjing Hospital Affiliated to Nanjing Medical University, Nanjing First Hospital, Nanjing 210006, P. R. China;
CHENXin, Email: stevecx1@163.com
Ischemic mitral regurgitation; Mitral valve repair; Mitral valve replacement
10.7507/1007-4848.20150208
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective To summarize the clinical experience in the treatment of Carpentier's type Ⅲb ischemic mitral regurgitation through the mitral valve repair versus mitral valve replacement, and to evaluate the early and midlong term effects. Methods We retrospectively analyzed the clinical data of 308 consecutive patients with type Ⅲb ischemic mitral regurgitation undergoing coronary artery bypass grafting (CABG) with mitral valve repair (a repair group, n=172) or with mitral valve replacement (a replacement group, n=136) in our hospital between January 2000 and March 2014. Among the 308 patients, 215 were males and 93 were females with mean age of 62.7±11.5 years(ranged 30-78 years). In the repair group, 170 patients underwent restrictive mitral annuloplasty (128 patients with total ring, 42 patients with C ring), and 2 patients underwent commissural constriction. In the replacement group, 11 patients underwent mechanical valve prosthesis and 125 patients underwent biological valve prosthesis. Results The time of total aortic cross-clamp was 81.9±21.5 min. The time of total extracorporeal circulation was 122.0±31.3 min. Six patients died during the perioperative period. No significant differences were observed between the two groups in general information (P>0.05). There were no significant differences between the two groups in aortic cross-clamp time, total extracorporeal circulation time, numbers of bypass grafts and the usage rate of left internal mammary artery. The early result after the surgery showed that the incidence rates of low cardiac output and ventricular arrhythmia were significantly higher in the replacement group compared with those in the repair group. The patients were followed up for 1-85 months. No significant difference was revealed in the mid-long term survival rate between the two groups. The severity of mitral regurgitation and the rate of redo mitral valve replacement were significantly lower in the replacement group compared with those in the repair group (P<0.05). Conclusion The early-term curative effect of valve repair is better than valve replacement for the treatment of Carpentier's type Ⅲb ischemic mitral regurgitation. In mid-long term, Chordal-sparing mitral valve replacement remains a low incidence of valve-related complications compared with mitral valve repair.

Citation： QIUZhi-bing, CHENXin, XUMing, WANGLi-ming, JIANGYing-shuo, HUANGFu-hua, XIAOLi-qiong, YANGTing, ZHANGYang-bo. Early and Mid-long Term Effects of Surgical Treatment Methods for Type Ⅲb Ischemic Mitral Regurgitation. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(9): 831-836. doi: 10.7507/1007-4848.20150208 Copy

  • Previous Article

    Early Result of Fenestration on Total Cavopulmonary Connection

  • Next Article

    Short- and Mid-term Effect of Surgical Treatment for Hypertrophic Obstructive Cardiomyopathy